Skip to main content

AGNG

ETF
—
—

Performance overview

AGNG Price
Price Chart

Forward-looking statistics

Beta
0.58
Risk
12.47%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.50%
Asset classEquities

Top holdings

Welltower Inc.4.53%
Boston Scientific Corp.4.08%
Chugai Pharmaceutical Co.3.77%
AbbVie Inc.3.50%
Bristol-Myers Squibb Co.3.47%
Roche Holding AG-BR3.33%
Amgen Inc.3.27%
UCB SA3.17%
Alcon Inc.3.07%
Other67.81%

Sector exposure

Health Care91.10%
Real Estate8.90%
Other0.00%

Country exposure

United States53.80%
Switzerland11.50%
Japan8.00%
United Kingdom4.60%
China4.40%
Denmark4.10%
Belgium3.30%
Ireland3.10%
South Korea2.50%
Other4.70%

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNASDAQ
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$0.28
Revenue per share—
Avg trading volume (30 day)$307K
Avg trading volume (10 day)$558K
Put-call ratioN/A

Macro factor sensitivity

Growth+0.3
Credit+2.2
Liquidity-0.2
Inflation-1.7
Commodities-0.1
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayJune 27, 2025

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free